Blog Layout
The Impact of BMI on IP Therapy
By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund • May 25, 2016
(May 25, 2016) A new study published in the International Journal of Gynecological Cancer earlier this month investigated the impact of the impact of body mass index (BMI) on completion, complications, and clinical outcomes of intraperitoneal (IP) chemotherapy in patients with advanced-stage ovarian cancer. The study followed ninety two patients through a minimum of one […]
